Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (2264)
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
10,000
Price
$28.09
Total Value
$280.86K
Shares Held After
105,211
% of Holdings
8.7%
Privia Health Group, Inc. (PRVA)
Mehrotra Parth — Director
Shares
26,509
Price
$22.11
Total Value
$586.11K
Shares Held After
555,443
% of Holdings
4.6%
Allogene Therapeutics, Inc. (ALLO)
Beneski Benjamin Machinas — SVP, Chief Technical Officer
Shares
4,835
Price
$2.47
Total Value
$11.94K
Shares Held After
198,205
% of Holdings
2.4%
Allogene Therapeutics, Inc. (ALLO)
Chang David D — Director
Shares
47,763
Price
$2.47
Total Value
$117.97K
Shares Held After
5,150,599
% of Holdings
0.9%
DEXCOM INC (DXCM)
Brown Michael Jon — EVP, Chief Legal Officer
Shares
1,700
Price
$64.85
Total Value
$110.24K
Shares Held After
112,904
% of Holdings
1.5%
Opus Genetics, Inc. (IRD)
Jayagopal Ashwath — Chief Scientific & Dev. Ofc.
Shares
3,719
Price
$5.12
Total Value
$19.05K
Shares Held After
516,775
% of Holdings
0.7%
Opus Genetics, Inc. (IRD)
SCHACHLE JOSEPH K — Chief Operating Officer
Shares
3,719
Price
$5.25
Total Value
$19.53K
Shares Held After
300,781
% of Holdings
1.2%
Axogen, Inc. (AXGN)
DeVinney Erick Wayne — Chief Innovation Officer
Shares
5,221
Price
$32.84
Total Value
$171.46K
Shares Held After
262,781
% of Holdings
1.9%
Avalo Therapeutics, Inc. (AVTX)
Doyle Mittie — Chief Medical Officer
Shares
25,492
Price
$16.15
Total Value
$411.61K
Shares Held After
3,622
% of Holdings
87.6%
Privia Health Group, Inc. (PRVA)
Mountcastle David — EVP & Chief Financial Officer
Shares
6,391
Price
$22.11
Total Value
$141.31K
Shares Held After
220,413
% of Holdings
2.8%
Opus Genetics, Inc. (IRD)
Magrath George — Director
Shares
24,438
Price
$5.21
Total Value
$127.33K
Shares Held After
1,750,855
% of Holdings
1.4%
BIOCRYST PHARMACEUTICALS INC (BCRX)
Barnes Alane P — Chief Legal Officer
Shares
150,000
Price
$9.15
Total Value
$1.37M
Shares Held After
400,703
% of Holdings
27.2%
Tarsus Pharmaceuticals, Inc. (TARS)
LINK WILLIAM J PHD — Director
Shares
493
Price
$69.75
Total Value
$34.39K
Shares Held After
116,332
% of Holdings
0.4%
Tarsus Pharmaceuticals, Inc. (TARS)
LINK WILLIAM J PHD — Director
Shares
8,378
Price
$69.03
Total Value
$578.33K
Shares Held After
116,825
% of Holdings
6.7%
Tarsus Pharmaceuticals, Inc. (TARS)
LINK WILLIAM J PHD — Director
Shares
3,629
Price
$68.09
Total Value
$247.10K
Shares Held After
125,203
% of Holdings
2.8%
Opus Genetics, Inc. (IRD)
Zaremba Rabourn Amy — Head of Fin. Quality Assurance
Shares
2,816
Price
$5.25
Total Value
$14.77K
Shares Held After
190,312
% of Holdings
1.5%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
1,991
Price
$101.68
Total Value
$202.44K
Shares Held After
2,242,500
% of Holdings
0.1%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
3,009
Price
$101.18
Total Value
$304.45K
Shares Held After
2,244,491
% of Holdings
0.1%
HARVARD BIOSCIENCE INC (HBIO)
Snider William — Director
Shares
12,525
Price
$4.99
Total Value
$62.50K
Shares Held After
23,525
% of Holdings
53.2%
ADMA BIOLOGICS, INC. (ADMA)
Grossman Adam S — Director
Shares
6,000
Price
$15.16
Total Value
$90.96K
Shares Held After
2,112,777
% of Holdings
0.3%
ADMA BIOLOGICS, INC. (ADMA)
Grossman Adam S — Director
Shares
15,000
Price
$15.16
Total Value
$227.40K
Shares Held After
2,118,777
% of Holdings
0.7%
OMNICELL, INC. (OMCL)
Manley Corey J — EVP&CHIEF LEGAL/ADMIN OFFICER
Shares
7,405
Price
$34.69
Total Value
$256.88K
Shares Held After
96,717
% of Holdings
7.1%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
733
Price
$41.30
Total Value
$30.27K
Shares Held After
31,767
% of Holdings
2.3%
Fortrea Holdings Inc. (FTRE)
Mcconnell Jill G. — Chief Financial Officer
Shares
1,804
Price
$9.22
Total Value
$16.63K
Shares Held After
72,276
% of Holdings
2.4%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
641
Price
$41.30
Total Value
$26.47K
Shares Held After
33,377
% of Holdings
1.9%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
1,177
Price
$41.94
Total Value
$49.36K
Shares Held After
34,018
% of Holdings
3.3%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
2,902
Price
$41.20
Total Value
$119.57K
Shares Held After
35,195
% of Holdings
7.6%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
2,921
Price
$40.11
Total Value
$117.16K
Shares Held After
38,097
% of Holdings
7.1%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
395
Price
$41.30
Total Value
$16.31K
Shares Held After
18,863
% of Holdings
2.1%
Oruka Therapeutics, Inc. (ORKA)
Sandler Laura Lee — Chief Operating Officer
Shares
600
Price
$41.30
Total Value
$24.78K
Shares Held After
236,984
% of Holdings
0.3%
Fortrea Holdings Inc. (FTRE)
Morais Mark A. — Chief Operating Officer
Shares
1,804
Price
$9.22
Total Value
$16.63K
Shares Held After
69,899
% of Holdings
2.5%
Oruka Therapeutics, Inc. (ORKA)
Klein Lawrence Otto — Director
Shares
1,729
Price
$41.30
Total Value
$71.41K
Shares Held After
927,309
% of Holdings
0.2%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
40,985
Price
$91.98
Total Value
$3.77M
Shares Held After
194,309
% of Holdings
17.4%
Mirum Pharmaceuticals, Inc. (MIRM)
Quan Joanne — CHIEF MEDICAL OFFICER
Shares
7,287
Price
$91.98
Total Value
$670.24K
Shares Held After
18,864
% of Holdings
27.9%
Mirum Pharmaceuticals, Inc. (MIRM)
Howe Jolanda — SVP, GLOBAL CONTROLLER
Shares
4,732
Price
$91.98
Total Value
$435.24K
Shares Held After
8,429
% of Holdings
36.0%
Mirum Pharmaceuticals, Inc. (MIRM)
Ramasastry Saira — Director
Shares
2,000
Price
$90.76
Total Value
$181.52K
Shares Held After
0
% of Holdings
100.0%
Mirum Pharmaceuticals, Inc. (MIRM)
Radovich Peter — PRESIDENT AND COO
Shares
16,515
Price
$91.98
Total Value
$1.52M
Shares Held After
40,272
% of Holdings
29.1%
Mirum Pharmaceuticals, Inc. (MIRM)
BJERKHOLT ERIC — CHIEF FINANCIAL OFFICER
Shares
7,287
Price
$91.98
Total Value
$670.24K
Shares Held After
49,788
% of Holdings
12.8%
iRhythm Holdings, Inc. (IRTC)
Smith Mervin — EVP Strategic Business Ops
Shares
2,585
Price
$114.30
Total Value
$295.47K
Shares Held After
23,027
% of Holdings
10.1%
Guardant Health, Inc. (GH)
Bell Michael Brian — Chief Financial Officer
Shares
3,000
Price
$87.04
Total Value
$261.11K
Shares Held After
43,601
% of Holdings
6.4%
GILEAD SCIENCES, INC. (GILD)
Mercier Johanna — Chief Comm & Corp Aff Officer
Shares
3,000
Price
$144.23
Total Value
$432.69K
Shares Held After
131,779
% of Holdings
2.2%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
126
Price
$26.68
Total Value
$3.36K
Shares Held After
40,779
% of Holdings
0.3%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
17,449
Price
$25.96
Total Value
$453.05K
Shares Held After
40,905
% of Holdings
29.9%
Upstream Bio, Inc. (UPB)
Ambrose Allison — General Counsel
Shares
475
Price
$9.29
Total Value
$4.41K
Shares Held After
16,525
% of Holdings
2.8%
Upstream Bio, Inc. (UPB)
Sutherland Everett Rand — Director
Shares
2,093
Price
$9.29
Total Value
$19.44K
Shares Held After
72,907
% of Holdings
2.8%
Terns Pharmaceuticals, Inc. (TERN)
Burroughs Amy L. — Director
Shares
2,770
Price
$47.30
Total Value
$131.03K
Shares Held After
288,976
% of Holdings
0.9%
Terns Pharmaceuticals, Inc. (TERN)
Burroughs Amy L. — Director
Shares
11,813
Price
$46.57
Total Value
$550.08K
Shares Held After
291,746
% of Holdings
3.9%
GILEAD SCIENCES, INC. (GILD)
Dickinson Andrew D — Chief Financial Officer
Shares
3,000
Price
$144.23
Total Value
$432.69K
Shares Held After
179,191
% of Holdings
1.6%
Upstream Bio, Inc. (UPB)
Deykin Aaron — Chief Medical Officer
Shares
894
Price
$9.29
Total Value
$8.31K
Shares Held After
32,687
% of Holdings
2.7%
Upstream Bio, Inc. (UPB)
GRAY MICHAEL — CFO and COO
Shares
852
Price
$9.29
Total Value
$7.92K
Shares Held After
29,648
% of Holdings
2.8%
Showing 251–300 of 2264 transactions (page 6 of 46)